The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

56Citations
Citations of this article
112Readers
Mendeley users who have this article in their library.

Abstract

Liquid biopsy is an emerging technology with a potential role in the screening and early detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and are currently under ongoing investigation. In this article, we review the available data on the use of circulating biomarkers for the early detection of lung cancer, focusing on the circulating tumor cells, circulating cell-free DNA, circulating micro-RNAs, tumor-derived exosomes, and tumor-educated platelets, providing an overview of future potential applicability in the clinical practice. While several biomarkers have shown exciting results, diagnostic performance and clinical applicability is still limited. The combination of different biomarkers, as well as their combination with other diagnostic tools show great promise, although further research is still required to define and validate the role of liquid biopsies in clinical practice.

Cite

CITATION STYLE

APA

Freitas, C., Sousa, C., Machado, F., Serino, M., Santos, V., Cruz-Martins, N., … Hespanhol, V. (2021, April 16). The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.634316

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free